Overseas business for brain ischemic therapy with adult stem cells.
Published: 2005-12-19 06:58:00
Updated: 2005-12-19 06:58:00
Korea Health Industry Development Institute (KHIDI) recently said that FCB pharmicell, a venture company specialized with adult stem cell research, would export their brain ischemic disease therapy by use of adult stem cells that was developed by themselves to Germany.
For this task, the KHIDI...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
